Goldman Sachs initiated coverage on Dynavax Technologies with a new price target

8/6/21 5:09:56 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Goldman Sachs initiated coverage of Dynavax Technologies with a rating of Buy and set a new price target of $19.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$DVAX

Date	Price Target	Rating	Analyst
2/11/2025	$15.00 → $12.00	Neutral → Sell	Goldman
2/1/2024	$20.00	Neutral	Goldman
9/27/2022	$22.00	Mkt Outperform	JMP Securities
1/6/2022	$38.00	Buy	Goldman
12/29/2021	$23.00 → $28.00	Buy	HC Wainwright & Co.
8/31/2021	$20.00 → $23.00	Buy	HC Wainwright & Co.
8/6/2021	$19.00	Buy	Goldman Sachs
8/5/2021	$16.00 → $20.00	Buy	HC Wainwright & Co.